Exponent (NASDAQ:EXPO) Issues Earnings Results

Exponent (NASDAQ:EXPO) issued its quarterly earnings data on Thursday. The business services provider reported $0.64 earnings per share for the quarter, topping analysts’ consensus estimates of $0.60 by $0.04, FiscalAI reports. Exponent had a net margin of 17.40% and a return on equity of 33.82%. The business had revenue of $173.73 million during the quarter, compared to the consensus estimate of $149.64 million. During the same quarter in the prior year, the firm posted $0.55 earnings per share. The company’s revenue was up 11.7% compared to the same quarter last year.

Here are the key takeaways from Exponent’s conference call:

• Strong third-quarter performance: Net revenue rose 12% to $153.1 million, EBITDA increased 16% with margin expanding to 29.4%, and utilization reached 76.7%. The company cited broad-based demand across user research, disputes, failure analysis, and product safety.
• Exponent raised its full-year 2026 outlook to 10%-11% net revenue growth and 28%-28.3% EBITDA margin, up from 27.6% in 2025. Management expects strong business activity to continue despite seasonally lower fourth-quarter utilization.
• AI-related work now represents an estimated 15%-20% of the business, spanning data-center infrastructure, advanced transportation systems, user research, product safety, and explainability of AI-driven decisions. Management said inquiries are increasing as AI moves into physical products and real-world applications.
• The engineering and scientific segment grew 13%, while environmental and health revenue increased only 3%. Management is investing in senior talent and emerging-chemical capabilities, including PFAS-related work, to support a future reacceleration.
• Exponent returned capital through $171 million of stock repurchases over the past 12 months, reducing diluted shares outstanding by 5%, and paid $14.7 million in dividends during the quarter. No shares were repurchased in the third quarter, but $50 million remains authorized for future buybacks.

Exponent Stock Performance

Shares of NASDAQ EXPO opened at $80.26 on Friday. The firm has a fifty day moving average of $70.19 and a 200 day moving average of $66.64. The firm has a market cap of $3.82 billion, a PE ratio of 34.59 and a beta of 0.69. Exponent has a one year low of $51.91 and a one year high of $83.18.

Exponent Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 18th. Investors of record on Friday, December 4th will be issued a $0.31 dividend. This represents a $1.24 annualized dividend and a yield of 1.5%. The ex-dividend date of this dividend is Friday, December 4th. Exponent’s payout ratio is presently 53.45%.

Insider Transactions at Exponent

In other Exponent news, CEO Catherine Corrigan sold 1,707 shares of the stock in a transaction on Monday, August 17th. The shares were sold at an average price of $66.28, for a total transaction of $113,139.96. Following the transaction, the chief executive officer directly owned 129,108 shares of the company’s stock, valued at $8,557,278.24. This trade represents a 1.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.70% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on EXPO. JPMorgan Chase & Co. raised their target price on Exponent from $90.00 to $100.00 and gave the company an “overweight” rating in a research report on Friday. UBS Group set a $72.00 price target on Exponent and gave the stock a “neutral” rating in a report on Friday, July 31st. Finally, Weiss Ratings raised Exponent from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, October 9th. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, Exponent presently has an average rating of “Moderate Buy” and an average price target of $86.00.

Trending Headlines about Exponent

Here are the key news stories impacting Exponent this week:

• Positive Sentiment: Quarterly earnings and revenue topped estimates. Exponent reported third-quarter EPS of $0.64, above the $0.60 consensus estimate and up from $0.55 a year earlier. Revenue reached $173.7 million versus an expected $149.6 million, while year-over-year revenue increased 11.7%. Exponent Tops Q3 Earnings and Revenue Estimates
• Positive Sentiment: Profitability and cash generation remained solid. Reported net income was approximately $30.9 million, operating profit increased sharply, and operating cash flow was $30.9 million. The results indicate improving operating leverage as revenue expands. Exponent Releases Q3 2026 Earnings
• Positive Sentiment: Management raised its 2026 outlook. The improved guidance reinforces investor expectations for continued growth and supports the positive reaction to the earnings release. Exponent Posts Strong Q3 Results
• Positive Sentiment: The company declared a regular quarterly dividend of $0.31 per share. The dividend is payable December 18 to shareholders of record December 4, representing an annualized payout of $1.24 and a yield of roughly 1.5%. Exponent Declares Quarterly Dividend
• Neutral Sentiment: Exponent plans to acquire Crane Building Services & Utilities in a carve-out transaction. The deal could broaden its service offering, although financial terms and expected earnings benefits were not provided. Exponent to Acquire Crane Building Services and Utilities
• Negative Sentiment: Recent insider trading has been weighted toward selling, with 10 reported sales and only one purchase over the past six months. This may create a modest sentiment headwind, though it is less significant than the earnings beat.

Exponent Company Profile

Exponent, Inc is a science and engineering consulting company that helps clients investigate complex technical issues, manage risks, and develop solutions. Its consultants work across disciplines including engineering, materials science, biomechanics, human factors, environmental science, health, data sciences, and economics.

The company provides failure analysis, product safety and testing, accident reconstruction, environmental and health assessments, regulatory support, and expert testimony.